(Total Views: 433)
Posted On: 04/26/2025 7:29:03 AM
Post# of 151984
Will the reported end of animal testing impact the project? Obvi hoping this study is not affected.
Quote:
To this end we will develop a novel formulation of long-acting Leronlimab that can be administered at home in a low volume able to provide coverage for three months. In specific aim 1, we will determine the pK and receptor occupancy of this new Leronlimab formulation in blood and tissue sites of sexual transmission. In specific aim 2, we will determine the length of time a single injection at the clinical dose can protect both male and female macaques against rectal transmission. In specific aim 3, we will determine the length of time a single injection of the clinical dose can protect against vaginal transmission in cycling female macaques.
(2)
(0)Scroll down for more posts ▼
